[go: up one dir, main page]

CN108721683A - A kind of preparation method of biodegradable hemostasis mesh sheet - Google Patents

A kind of preparation method of biodegradable hemostasis mesh sheet Download PDF

Info

Publication number
CN108721683A
CN108721683A CN201810499233.9A CN201810499233A CN108721683A CN 108721683 A CN108721683 A CN 108721683A CN 201810499233 A CN201810499233 A CN 201810499233A CN 108721683 A CN108721683 A CN 108721683A
Authority
CN
China
Prior art keywords
polyethylene glycol
biodegradable
mesh
preparation
mesh sheet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810499233.9A
Other languages
Chinese (zh)
Inventor
竺亚斌
何斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningbo Bao Ting Biotechnology Co Ltd
Original Assignee
Ningbo Bao Ting Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningbo Bao Ting Biotechnology Co Ltd filed Critical Ningbo Bao Ting Biotechnology Co Ltd
Priority to CN201810499233.9A priority Critical patent/CN108721683A/en
Publication of CN108721683A publication Critical patent/CN108721683A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001Use of materials characterised by their function or physical properties
    • A61L24/0042Materials resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)

Abstract

本发明公开了一种生物降解止血网片的制备方法,特点是先制备聚乙二醇‑聚(L‑丙交酯‑乙交酯‑ε‑己内酯)的多嵌段共聚物,再对其进行纺丝编织成网片,得到生物降解止血网片;优点是所制备的聚乙二醇‑聚(L‑丙交酯‑乙交酯‑ε‑己内酯)多嵌段共聚物柔顺性好,纺成纤维后手感柔软,克服了天然高分子止血网片硬而糙的缺陷;而且止血网片的组成成份都可被人体酶降解,因此其具有很好的生物相容性;此外,通过熔融纺丝成型为网片,其制备方法更加绿色环保,使用起来因无溶剂残留而更安全、对人体组织的副作用更小。The invention discloses a preparation method of a biodegradable hemostatic mesh, which is characterized in that a multi-block copolymer of polyethylene glycol-poly(L-lactide-glycolide-ε-caprolactone) is prepared first, and It is spun and woven into a mesh to obtain a biodegradable hemostatic mesh; the advantage is that the prepared polyethylene glycol-poly(L-lactide-glycolide-ε-caprolactone) multi-block copolymer Good flexibility, soft hand feeling after spinning into fibers, which overcomes the hard and rough defects of natural polymer hemostatic mesh; and the components of hemostatic mesh can be degraded by human enzymes, so it has good biocompatibility; In addition, it is formed into a mesh by melt spinning, and its preparation method is more green and environmentally friendly. It is safer to use because there is no solvent residue, and has less side effects on human tissues.

Description

一种生物降解止血网片的制备方法A kind of preparation method of biodegradable hemostatic mesh

技术领域technical field

本发明涉及医用止血材料的制备方法,尤其涉及一种生物降解止血网片的制备方法。The invention relates to a preparation method of a medical hemostatic material, in particular to a preparation method of a biodegradable hemostatic mesh.

背景技术Background technique

外科微创手术在全球范围内非常广泛,微创手术因为可操作空间小使切割后的组织只能通过填塞止血,且不宜再次手术取出,因此,可吸收止血材料在微创手术中得到了广泛的应用。目前临床使用的可吸收止血材料以羧甲基纤维素钠为主,这类材料能够被体内的多种酶降解为小片段或小分子,继而被身体吸收或排出。然而,羧甲基纤维素钠的降解产物为酸性物质,容易在局部组织中引起酸性过大而对组织产生危害。同时,羧甲基纤维素钠由纤维素经化学反应制得,原材料纤维素可能存在来源不同、质量不稳定、材料性能差异大等问题,编成网片后不仅质感较硬,而且由于亲水性不够好而导致吸液率和吸液速率均需进一步提高。而且,由于纤维素分子量大,很难制成均相溶液,对其改性的化学反应不能均匀地在整个分子链上发生,从而导致羧甲基纤维素钠材料的性能不均匀,影响其止血的有效性。Surgical minimally invasive surgery is very widespread in the world. Because of the small operable space, the cut tissue can only be hemostasis through packing, and it is not suitable for reoperation. Therefore, absorbable hemostatic materials have been widely used in minimally invasive surgery. Applications. The currently clinically used absorbable hemostatic material is mainly sodium carboxymethyl cellulose, which can be degraded by various enzymes in the body into small fragments or small molecules, and then absorbed or excreted by the body. However, the degradation products of sodium carboxymethyl cellulose are acidic substances, which can easily cause excessive acidity in local tissues and cause damage to tissues. At the same time, sodium carboxymethyl cellulose is made from cellulose through chemical reactions. The raw material cellulose may have problems such as different sources, unstable quality, and large differences in material properties. The performance is not good enough, so the liquid absorption rate and liquid absorption rate need to be further improved. Moreover, due to the large molecular weight of cellulose, it is difficult to make a homogeneous solution, and the chemical reaction to its modification cannot occur uniformly on the entire molecular chain, resulting in uneven performance of the sodium carboxymethyl cellulose material and affecting its hemostasis. effectiveness.

除羧甲基纤维素钠外,还有一类较多见的止血材料为胶原和明胶等蛋白类高分子。这类材料由于其是动物来源的,在使用过程中容易发生免疫激活、微生物及病毒感染等潜在的风险,尤其在出血量多需要使用较多此类产品时,风险更大。另一方面,蛋白质类材料由于产地、饲养时间、动物种类、后期处理方式等差异,使其产品在性能上产生极大的差异和不稳定性。In addition to sodium carboxymethyl cellulose, there is another kind of more common hemostatic materials such as protein polymers such as collagen and gelatin. Because such materials are of animal origin, potential risks such as immune activation, microbial and viral infection are prone to occur during use, especially when a large amount of bleeding requires the use of more such products, the risk is even greater. On the other hand, due to differences in origin, breeding time, animal species, and post-processing methods of protein materials, the performance of protein materials has great differences and instability.

发明内容Contents of the invention

本发明所要解决的技术问题是提供一种质感柔软、安全性好、副作用小且降解速率可调的生物降解止血网片的制备方法。The technical problem to be solved by the present invention is to provide a method for preparing a biodegradable hemostatic mesh with soft texture, good safety, few side effects and adjustable degradation rate.

本发明解决上述技术问题所采用的技术方案为:一种生物降解止血网片的制备方法,包括以下具体步骤:The technical scheme adopted by the present invention to solve the above-mentioned technical problems is: a preparation method of a biodegradable hemostatic mesh, comprising the following specific steps:

(1)、称取重均分子量为2000~10000的聚乙二醇放入反应釜中,并加入摩尔比为1:1:1的L-丙交酯、乙交酯、ε-己内酯的混合物,控制聚乙二醇与混合物的质量比为1:1~5,再加入与聚乙二醇和混合物的总质量比为0.001~0.1%的辛酸亚锡,在120~160℃温度下氩气保护环境中反应20~40小时;(1) Weigh polyethylene glycol with a weight-average molecular weight of 2000-10000 and put it into the reaction kettle, and add L-lactide, glycolide and ε-caprolactone at a molar ratio of 1:1:1 The mixture, control the mass ratio of polyethylene glycol to the mixture is 1:1-5, then add stannous octoate with a total mass ratio of 0.001-0.1% to polyethylene glycol and the mixture, and argon at 120-160°C Reaction in gas protection environment for 20 to 40 hours;

(2)、加入与聚乙二醇等摩尔比的扩链剂,在100~150℃的温度下氩气保护环境中搅拌反应20~40小时,得到聚乙二醇-聚(L-丙交酯-乙交酯-ε-己内酯)的多嵌段共聚物;(2) Add a chain extender in an equimolar ratio to polyethylene glycol, stir and react for 20-40 hours in an argon-protected environment at a temperature of 100-150°C to obtain polyethylene glycol-poly(L-lactate) ester-glycolide-ε-caprolactone) multi-block copolymer;

(3)、将上述得到的多嵌段共聚物造粒,通过熔融纺丝得到纤维直径为0.1~0.5mm的纤维丝,再将纤维丝通过编织机按需要编成多种孔径的网片,得到生物降解止血网片。(3) Granulate the multi-block copolymer obtained above, obtain fiber filaments with a fiber diameter of 0.1 to 0.5 mm by melt spinning, and then weave the fiber filaments into mesh sheets with various apertures as required by a weaving machine. A biodegradable hemostatic mesh is obtained.

进一步地,所述的扩链剂为环己基1,4-二异氰酸酯、4,4′-亚甲基双异氰酸苯酯、4,4′-二异氰酸酯二环己基甲烷或六亚甲基二异氰酸酯。Further, the chain extender is cyclohexyl 1,4-diisocyanate, 4,4'-methylene diisocyanate phenyl, 4,4'-diisocyanate dicyclohexylmethane or hexamethylene diisocyanate.

与现有技术相比,本发明的优点是所制备的聚乙二醇-聚(L-丙交酯-乙交酯-ε-己内酯)多嵌段共聚物柔顺性好,纺成纤维后手感柔软,克服了天然高分子止血网片硬而糙的缺陷;且止血网片的组成成份都可被人体酶降解,因此其具有很好的生物相容性;由L-丙交酯、乙交酯和ε-己内酯三种单体聚合得到的共聚物,可灵活地根据需要调节组分配比从而调节其降解速率,以更好地匹配组织应用需要;此外,通过熔融纺丝成型为网片,其制备方法更加绿色环保,使用起来因无溶剂残留而更安全、对人体组织的副作用更小。Compared with the prior art, the present invention has the advantages that the prepared polyethylene glycol-poly(L-lactide-glycolide-ε-caprolactone) multi-block copolymer has good flexibility and can be spun into fibers The back feels soft, overcoming the hard and rough defects of natural polymer hemostatic mesh; and the components of the hemostatic mesh can be degraded by human enzymes, so it has good biocompatibility; L-lactide, The copolymer obtained by polymerization of three monomers of glycolide and ε-caprolactone can flexibly adjust the proportion of components according to needs to adjust its degradation rate to better match the needs of tissue applications; in addition, it can be formed by melt spinning It is a mesh, its preparation method is more green and environmentally friendly, it is safer to use because there is no solvent residue, and it has less side effects on human tissues.

具体实施方式Detailed ways

以下结合实施例对本发明作进一步详细描述。Below in conjunction with embodiment the present invention is described in further detail.

实施例一:一种生物降解止血网片的制备方法,包括以下具体步骤:Embodiment 1: A kind of preparation method of biodegradable hemostatic mesh, comprises the following specific steps:

(1)、称取重均分子量(Mw)为2000的聚乙二醇放入反应釜中,并加入摩尔比为1:1:1的L-丙交酯、乙交酯、ε-己内酯的混合物,控制聚乙二醇与混合物的质量比为1:1,再加入与聚乙二醇和混合物的总质量比为0.01%的辛酸亚锡,在120℃温度下氩气保护环境中反应40小时;(1) Weigh polyethylene glycol with a weight average molecular weight (Mw) of 2000 and put it into the reaction kettle, and add L-lactide, glycolide, ε-hexanol in a molar ratio of 1:1:1 A mixture of esters, control the mass ratio of polyethylene glycol and the mixture to 1:1, then add stannous octoate with a total mass ratio of polyethylene glycol and the mixture of 0.01%, and react at a temperature of 120°C in an argon-protected environment 40 hours;

(2)、加入与聚乙二醇等摩尔比的环己基1,4-二异氰酸酯,在100℃的温度下氩气保护环境中搅拌反应40小时,得到聚乙二醇-聚(L-丙交酯-乙交酯-ε-己内酯)的多嵌段共聚物;(2) Add cyclohexyl 1,4-diisocyanate in an equimolar ratio to polyethylene glycol, and stir and react for 40 hours at a temperature of 100°C in an argon-protected environment to obtain polyethylene glycol-poly(L-propane multi-block copolymers of lactide-glycolide-ε-caprolactone);

(3)、将上述得到的多嵌段共聚物造粒,通过熔融纺丝得到纤维直径为0.3mm的纤维丝,再将纤维丝通过编织机按需要编成多种孔径的网片,得到生物降解止血网片。(3) Granulate the multi-block copolymer obtained above, obtain fiber filaments with a fiber diameter of 0.3 mm by melt spinning, and then weave the fiber filaments into meshes with various apertures as required by a weaving machine to obtain biological Degrade the hemostatic mesh.

实施例二:一种生物降解止血网片的制备方法,包括以下具体步骤:Embodiment 2: A preparation method of a biodegradable hemostatic mesh, comprising the following specific steps:

(1)、称取重均分子量(Mw)为10000的聚乙二醇放入反应釜中,并加入摩尔比为1:1:1的L-丙交酯、乙交酯、ε-己内酯的混合物,控制聚乙二醇与混合物的质量比为1:3,再加入与聚乙二醇和混合物的总质量比为0.1%的辛酸亚锡,在160℃温度下氩气保护环境中反应20小时;(1) Weigh polyethylene glycol with a weight-average molecular weight (Mw) of 10,000 and put it into the reactor, and add L-lactide, glycolide, ε-hexanol in a molar ratio of 1:1:1 A mixture of esters, control the mass ratio of polyethylene glycol and the mixture to 1:3, then add stannous octoate with a total mass ratio of polyethylene glycol and the mixture of 0.1%, and react in an argon-protected environment at a temperature of 160°C 20 hours;

(2)、加入与聚乙二醇等摩尔比的4,4′-亚甲基双异氰酸苯酯,在120℃的温度下氩气保护环境中搅拌反应30小时,得到聚乙二醇-聚(L-丙交酯-乙交酯-ε-己内酯)的多嵌段共聚物;(2) Add 4,4′-methylene diisocyanate phenyl in an equimolar ratio to polyethylene glycol, stir and react for 30 hours at a temperature of 120°C in an argon-protected environment to obtain polyethylene glycol - multi-block copolymers of poly(L-lactide-glycolide-ε-caprolactone);

(3)、将上述得到的多嵌段共聚物造粒,通过熔融纺丝得到纤维直径为0.1mm的纤维丝,再将纤维丝通过编织机按需要编成多种孔径的网片,得到生物降解止血网片。(3) Granulate the multi-block copolymer obtained above, obtain fiber filaments with a fiber diameter of 0.1 mm by melt spinning, and then weave the fiber filaments into meshes with various apertures as required by a weaving machine to obtain biological Degrade the hemostatic mesh.

实施例三:一种生物降解止血网片的制备方法,包括以下具体步骤:Embodiment three: a kind of preparation method of biodegradable hemostatic mesh, comprises the following specific steps:

(1)、称取重均分子量(Mw)为6000的聚乙二醇放入反应釜中,并加入摩尔比为1:1:1的L-丙交酯、乙交酯、ε-己内酯的混合物,控制聚乙二醇与混合物的质量比为1:5,再加入与聚乙二醇和混合物的总质量比为0.008%的辛酸亚锡,在140℃温度下氩气保护环境中反应35小时;(1) Weigh polyethylene glycol with a weight average molecular weight (Mw) of 6000 and put it into the reaction kettle, and add L-lactide, glycolide, ε-hexanol in a molar ratio of 1:1:1 A mixture of esters, control the mass ratio of polyethylene glycol to the mixture to 1:5, then add stannous octoate with a total mass ratio of 0.008% to polyethylene glycol and the mixture, and react in an argon-protected environment at a temperature of 140°C 35 hours;

(2)、加入与聚乙二醇等摩尔比的4,4′-二异氰酸酯二环己基甲烷,在150℃的温度下氩气保护环境中搅拌反应20小时,得到聚乙二醇-聚(L-丙交酯-乙交酯-ε-己内酯)的多嵌段共聚物;(2) Add 4,4′-diisocyanate dicyclohexylmethane in an equimolar ratio to polyethylene glycol, and stir and react for 20 hours at a temperature of 150°C in an argon-protected environment to obtain polyethylene glycol-poly( Multi-block copolymers of L-lactide-glycolide-ε-caprolactone);

(3)、将上述得到的多嵌段共聚物造粒,通过熔融纺丝得到纤维直径为0.5mm的纤维丝,再将纤维丝通过编织机按需要编成多种孔径的网片,得到生物降解止血网片。(3) Granulate the multi-block copolymer obtained above, obtain fiber filaments with a fiber diameter of 0.5 mm by melt spinning, and then weave the fiber filaments into meshes with various apertures as required by a weaving machine to obtain biological Degrade the hemostatic mesh.

Claims (2)

1. a kind of preparation method of biodegradable hemostasis mesh sheet, it is characterised in that including step in detail below:
(1), weigh weight average molecular weight be 2000~10000 polyethylene glycol be put into reaction kettle, and be added molar ratio be 1:1:1 L- lactides, glycolide, 6-caprolactone mixture, the mass ratio for controlling polyethylene glycol and mixture is 1:1~5, then add Enter the stannous octoate for being 0.001~0.1% with the total mass ratio of polyethylene glycol and mixture, argon gas at a temperature of 120~160 DEG C It is reacted 20~40 hours in environmental protection;
(2), be added with polyethylene glycol equimolar than chain extender, stirred in argon gas protection environment at a temperature of 100~150 DEG C Reaction 20~40 hours, obtains polyethylene glycol(L- lactide coglycolides -6-caprolactone)Segmented copolymer;
(3), segmented copolymer obtained above is granulated, the fibre that fibre diameter is 0.1~0.5mm is obtained by melt spinning Silk is tieed up, then filament is weaved into the mesh sheet of multiple aperture on demand by braider, obtains biodegradable hemostasis mesh sheet.
2. a kind of preparation method of biodegradable hemostasis mesh sheet as described in claim 1, it is characterised in that:The chain extender For cyclohexyl 1,4- diisocyanate, 4,4 '-di-2-ethylhexylphosphine oxide phenyl isocyanates, 4,4 '-hexylmethanes or Hexamethylene diisocyanate.
CN201810499233.9A 2018-05-23 2018-05-23 A kind of preparation method of biodegradable hemostasis mesh sheet Pending CN108721683A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810499233.9A CN108721683A (en) 2018-05-23 2018-05-23 A kind of preparation method of biodegradable hemostasis mesh sheet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810499233.9A CN108721683A (en) 2018-05-23 2018-05-23 A kind of preparation method of biodegradable hemostasis mesh sheet

Publications (1)

Publication Number Publication Date
CN108721683A true CN108721683A (en) 2018-11-02

Family

ID=63935294

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810499233.9A Pending CN108721683A (en) 2018-05-23 2018-05-23 A kind of preparation method of biodegradable hemostasis mesh sheet

Country Status (1)

Country Link
CN (1) CN108721683A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1771061A (en) * 2003-01-09 2006-05-10 聚合物器官股份有限公司 biomedical foam
CN103495211A (en) * 2013-10-15 2014-01-08 山东赛克赛斯药业科技有限公司 Absorbable anti-adhesive membrane for cardiac surgery and preparation method of absorbable anti-adhesive membrane
CN104031287A (en) * 2014-06-19 2014-09-10 山东赛克赛斯药业科技有限公司 Preparation method of biodegradable nasal hemostatic sponge
US8927001B2 (en) * 2005-06-15 2015-01-06 Poly-Med, Inc. Bioswellable, crystalline, amphiphilic, block/graft polymers and applications thereof
CN104744661A (en) * 2015-03-03 2015-07-01 宁波市医疗中心李惠利医院 Hydrophilic degradable segmented polyurethane as well as preparation method and application thereof
CN106279644A (en) * 2016-08-11 2017-01-04 江苏邦士医疗科技有限公司 A kind of Biodegradable high molecular absorbable hemostatic sponge and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1771061A (en) * 2003-01-09 2006-05-10 聚合物器官股份有限公司 biomedical foam
US8927001B2 (en) * 2005-06-15 2015-01-06 Poly-Med, Inc. Bioswellable, crystalline, amphiphilic, block/graft polymers and applications thereof
CN103495211A (en) * 2013-10-15 2014-01-08 山东赛克赛斯药业科技有限公司 Absorbable anti-adhesive membrane for cardiac surgery and preparation method of absorbable anti-adhesive membrane
CN104031287A (en) * 2014-06-19 2014-09-10 山东赛克赛斯药业科技有限公司 Preparation method of biodegradable nasal hemostatic sponge
CN104744661A (en) * 2015-03-03 2015-07-01 宁波市医疗中心李惠利医院 Hydrophilic degradable segmented polyurethane as well as preparation method and application thereof
CN106279644A (en) * 2016-08-11 2017-01-04 江苏邦士医疗科技有限公司 A kind of Biodegradable high molecular absorbable hemostatic sponge and preparation method thereof

Similar Documents

Publication Publication Date Title
US5695879A (en) Surgical suture material and method of making and using same
JP4554084B2 (en) Bioabsorbable, biocompatible polymers for tissue manipulation
EP2825581B1 (en) Segmented, semicrystalline poly(lactide-co-epsilon-caprolactone) absorbable copolymers
CA2645764C (en) Oxidized microbial cellulose and use thereof
JP6216933B2 (en) Bioabsorbable telechelic polymer composition with mechanical strength capable of controlling absorption rate with high accuracy, treatment method, and product obtained therefrom
Hemmatgir et al. Characterization of a novel semi-interpenetrating hydrogel network fabricated by polyethylene glycol diacrylate/polyvinyl alcohol/tragacanth gum as a wound dressing
US6048947A (en) Triblock terpolymer, its use for surgical suture material and process for its production
CN109982728A (en) The absorbable polymer blend composition of nucleation rate with enhancing
CN109790307A (en) Breathable film with microorganism barrier property
EP2218466A1 (en) Lactide/ -caprolactone copolymer for medical implant, method for producing lactide/ -caprolactone copolymer for medical implant, medical implant and artificial dura mater
JP2007525601A (en) Polyhydroxyalkanoate medical fabric and medical fiber
AU2014342970B2 (en) Absorbable poly (p-dioxanone-co-glycolide) monofilament fibers possessing mid-term strength retention post-implantation
CN111205445B (en) Amphiphilic block copolymer, absorbable bone wax and preparation method thereof
CN112316198A (en) Absorbable and degradable suture line
CN108721683A (en) A kind of preparation method of biodegradable hemostasis mesh sheet
CN107970493A (en) Absorbable closure apparatus
CN118576751A (en) A hemostatic sponge capable of disintegrating as a whole and its preparation method and application
EP1516006B1 (en) Block copolymers for surgical articles
EP2457598B1 (en) Resorbable membrane
EP3405223B1 (en) Segmented, p-dioxanone-rich, poly(p-dioxanone-co-epsilon-caprolactone) copolymers for medical applications and devices made therefrom
CN103951950B (en) Flexible biological degradable composite material
CN117511149B (en) Antibacterial breathable film and preparation method and application thereof
CN116966337B (en) A degradable polymer repair material and preparation method thereof
CN117414462B (en) Hemostatic granules for diffuse bleeding and preparation method and application thereof
CN109675094A (en) A kind of absorbable bone wax and preparation method thereof with hemostatic function

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20181102